What to know about Zyn, the tiny nicotine pouch that's sparked a big health debate

Zyn, a small nicotine pouch by Philip Morris, is sparking debates on the benefits and risks of new tobacco products. The pouch contains nicotine powder and flavors and is aimed at adult users. While Zyn is viewed as potentially less harmful than cigarettes, health risks persist. FDA is reviewing its market authorization amidst concerns about underage use. Limited studies suggest Zyn may not effectively help smokers quit. Despite low youth usage, worries exist about its popularity among teens. The FDA is monitoring the situation closely. Researchers point out similarities between Zyn and other cessation aids, though efficacy remains uncertain. Philip Morris aims for FDA authorization and possibly reduced-risk status.